VIRX - Viracta Therapeutics, Inc.

QQQ $ 612.14 $ 7.61 (1.26 %)

DIA $ 467.37 $ 5.24 (1.13 %)

SPY $ 671.96 $ 6.91 (1.04 %)

TLT $ 91.60 $ 0.35 (0.38 %)

GLD $ 400.80 $ 14.16 (3.64 %)

Previous Close

$ 0.00978

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.01 - $ 0.58

Volume

484,026

Average Volume

Market Cap

3.09M

Beta (5Y Monthly)

$ 0.11

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-13-2024	09-30-2024	10-Q
2	08-14-2024	06-30-2024	10-Q
3	05-09-2024	03-31-2024	10-Q
4	03-07-2024	12-31-2023	10-K
5	11-09-2023	09-30-2023	10-Q
6	08-14-2023	06-30-2023	10-Q
7	05-09-2023	03-31-2023	10-Q
8	03-14-2023	12-31-2022	10-K
9	11-10-2022	09-30-2022	10-Q
10	08-09-2022	06-30-2022	10-Q
11	05-10-2022	03-31-2022	10-Q
12	03-16-2022	12-31-2021	10-K
13	11-10-2021	09-30-2021	10-Q
14	08-12-2021	06-30-2021	10-Q
15	05-13-2021	03-31-2021	10-Q
16	02-24-2021	12-31-2020	10-K
17	11-16-2020	09-30-2020	10-Q
18	08-11-2020	06-30-2020	10-Q
19	05-07-2020	03-31-2020	10-Q
20	03-10-2020	12-31-2019	10-K
21	11-12-2019	09-30-2019	10-Q
22	08-07-2019	06-30-2019	10-Q
23	05-08-2019	03-31-2019	10-Q
24	03-07-2019	12-31-2018	10-K
25	11-05-2018	09-30-2018	10-Q
26	08-08-2018	06-30-2018	10-Q
27	05-08-2018	03-31-2018	10-Q
28	03-09-2018	12-31-2017	10-K
29	11-02-2017	09-30-2017	10-Q
30	07-27-2017	06-30-2017	10-Q
31	05-08-2017	03-31-2017	10-Q
32	03-09-2017	12-31-2016	10-K
33	11-03-2016	09-30-2016	10-Q
34	07-29-2016	06-30-2016	10-Q
35	05-09-2016	03-31-2016	10-Q
36	03-14-2016	12-31-2015	10-K
37	11-05-2015	09-30-2015	10-Q
38	07-30-2015	06-30-2015	10-Q
39	05-05-2015	03-31-2015	10-Q
40	03-12-2015	12-31-2014	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
02/03/2025 21:05:45

12 Health Care Stocks Moving In Monday's P...
02/03/2025 12:05:43

why-triumph-group-shares-are-trading-higher-by-over-36-here-are-20-stocks-moving-premarket

Why Triumph Group Shares Are Trading Highe...
02/03/2025 11:10:05

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
12/27/2024 21:05:49

castellum-viracta-therapeutics-and-3-stocks-to-watch-heading-into-friday-corrected

Castellum, Viracta Therapeutics And 3 Stoc...
12/27/2024 19:35:09

masimo-to-rally-more-than-13-here-are-5-top-analyst-forecasts-for-friday

Masimo To Rally More Than 13%? Here Are 5 ...
12/27/2024 14:03:58

us-stocks-to-open-lower-as-index-future-decline-analysts-remain-upbeat-about-santa-rally

US Stocks To Open Lower As Index Future De...
12/27/2024 12:35:24

U.S. stock futures tumbled on Friday in premarket hours after a mixed Thursday. All four index futures slipped in trade.

Rodman & Renshaw Downgrades Viracta Therap...
12/27/2024 12:33:17

Rodman & Renshaw downgrades Viracta Therapeutics (NASDAQ:VIRX) from Buy to Neutral and lowers the price target from $3.5 ...

why-evaxion-biotech-shares-are-trading-higher-by-around-62-here-are-20-stocks-moving-premarket

Why Evaxion Biotech Shares Are Trading Hig...
12/27/2024 10:03:48

$viracta-therapeutics-plans-to-close-its-ongoing-pivotal-phase-2-clinical-trial-of-nana-val-in-relapsedrefractory-ebv--lymphomas$

Viracta Therapeutics Plans To Close Its On...
12/26/2024 21:31:59

The company emphasized that its decision to voluntarily close the trial is not the result of any new safety finding.

Viracta Therapeutics Board Initiates Proce...
12/26/2024 21:30:56

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
12/04/2024 21:06:10

why-marvell-technology-shares-are-trading-higher-by-around-13-here-are-20-stocks-moving-premarket

Why Marvell Technology Shares Are Trading ...
12/04/2024 10:11:00

RBC Capital Maintains Outperform on Viract...
11/14/2024 17:08:54

RBC Capital analyst Gregory Renza maintains Viracta Therapeutics (NASDAQ:VIRX) with a Outperform and lowers the price target...

Viracta Therapeutics Q3 2024 GAAP EPS $(0....
11/13/2024 12:26:03

Viracta Therapeutics (NASDAQ:VIRX) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate o...

$viracta-therapeutics-to-reprioritize-resources-to-focus-on-nana-val-development-program-in-relapsed-or-refractory-ebv-positive-peripheral-t-cell-lymphoma-announces-42-force-reduction-sees-700k-in-total-expenses$

Viracta Therapeutics To Reprioritize Resou...
11/06/2024 22:32:27

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
09/27/2024 20:31:00

Leerink Partners Downgrades Viracta Therap...
08/16/2024 11:13:10

Leerink Partners analyst Andrew Berens downgrades Viracta Therapeutics (NASDAQ:VIRX) from Outperform to Market Perform and l...

RBC Capital Maintains Outperform on Viract...
08/15/2024 14:55:58

RBC Capital analyst Gregory Renza maintains Viracta Therapeutics (NASDAQ:VIRX) with a Outperform and lowers the price target...

Viracta Therapeutics shares are trading hi...
08/14/2024 13:22:04